This is the authors' abstract. We don't add key points for this paper.
To study the contribution of the measles virus fusion (F) protein in the immune response, anti-F monoclonal antibodies were prepared by using a vaccinia-measles virus F recombinant. In contrast to previously described anti-F monoclonal antibodies, these antibodies not only neutralized virus infectivity and inhibited fusion but also passively protected mice. Since these monoclonal antibodies recognize a configurational epitope, presentation of the antigen during infection may play an important role in the immune response. These factors are discussed in relation to vaccination.
Answers are grounded in this paper and cite their sources.
Anti-F mAbs may enable passive measles protection in models; leaves open human translation and epitope-based vaccine strategies.
No takes yet. Share an insight, caveat, or question.
Malvoisin et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: